Skip to content
Disclosery

Paradigm Biocapital Advisors LP: ERAS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on ERAS, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 9,550,000 ERAS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 9,550,000 shares
    Change vs previous 13F -842,702 shares

    3.28% of the 13F portfolio, value $174,956,000.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 10,392,702 shares
    Change vs previous 13F -3,766,393 shares

    3.44% of the 13F portfolio, value $168,153,918.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 14,159,095 shares
    Change vs previous 13F +599,078 shares

    1.41% of the 13F portfolio, value $52,671,833.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 13,560,017 shares
    Change vs previous 13F +1,652,835 shares

    0.87% of the 13F portfolio, value $29,560,837.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 11,907,182 shares
    Change vs previous 13F +1,104,828 shares

    0.65% of the 13F portfolio, value $15,122,121.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 10,802,354 shares
    Change vs previous 13F +50,000 shares

    0.68% of the 13F portfolio, value $14,799,225.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 10,752,354 shares
    Change vs previous 13F +84,213 shares

    0.94% of the 13F portfolio, value $26,988,409.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 10,668,141 shares
    Change vs previous 13F not available

    1.02% of the 13F portfolio, value $29,124,025.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).